Chain Bridge I CBRRF

10.31 0.00 0.00% as of 24 Sep
Market cap
$77.4M
P/E
0.0×

Insider Decisions

in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 82.43%

Capital & Financial Ratios

Market Cap 77.43
Revenue —
Net Income (1.58)
Free Cash Flow (0.98)
Net Debt 2.76
Current Ratio 0.24
Debt/Equity (0.65)
P/E ratio 0.00
P/S ratio 0.00
P/B ratio 0.00
Past 5Y EPS Growth —
This Y EPS Growth —
Next Y EPS Growth —
Next 5Y EPS Growth —
in millions of $

Dividends

Payout Ratio 0.00
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 0 0 0 0
Receivables — — — 0
Inventory — — — —
Other — — — —
0 0 0 0
2023 2024 2025 Q'26
Payables 0 0 0 0
ST’ Debt — — — —
Other — — — —
0 1 1 1
in millions of $

Compound Annual Growth

10y 5y 3y
Sales — — —
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — 0.00% 0.00%

Revenue

Year
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Mar Jun Sep Dec Year
’26 0 0 — — —
’25 0 0 0 0 (1)
’24 0 0 0 0 (1)
’23 0 0 0 0 (1)
’22 — — 0 0 (1)
’22 0 0 — — (1)
’21 — — 0 (1) (1)
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Mar Jun Sep Dec Year
’26 0 0 — — —
’25 0 0 0 0 (1)
’24 0 0 0 0 (1)
’23 0 0 0 0 (1)
’22 — — 0 0 (1)
’22 0 0 — — (1)
’21 — — 0 (1) (1)
in millions of $ · fiscal quarters ending in the months shown

EPS

Mar Jun Sep Dec Year
’26 (0.08) (0.03) — — —
’25 (0.06) 0.00 (0.23) 0.06 (0.23)
’24 (0.22) (0.08) 0.06 (0.01) (0.25)
’23 0.49 0.31 (0.08) 0.61 1.33
’22 — — 0.48 0.41 1.86
’22 0.43 0.55 — — 0.37
’21 — — (0.01) — 0.86
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

1Buy 2 3Hold 4 5Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
— — — — — — 9.81 9.65 10.80 11.02

Analyst estimates 2026–2028

Powerpack
Low Price
— — — — — — 10.30 10.99 12.69 12.08
High Price
— — — — — 2 2 2 2 2
Employees
— — — — — 0 0 0 0 0
Revenue/Emp
— — — — — — — — — —
Revenue
— — — — — — — — — —
Gross Margin
— — — — — 5 11 8 (1) (1)
EBT
— — — — — 0.00% 0.00% 0.00% 0.00% 0.00%
EBT Margin
— 0 — — — 5 11 8 (1) (1)
Net Income
— — — — — — — — — —
Depreciation
— — — — — 0.00 0.00 0.00 0.00 0.00
Revenue/Sh
— — — — — 0.86 1.86 1.33 (0.22) (0.20)
Earnings/Sh
— — — — — (0.15) (0.16) (0.16) (0.16) (0.13)
Cash Flow/Sh
— — — — — 0.00 0.00 0.00 0.00 0.00
Capex/Sh
— — — — — (0.15) (0.16) (0.16) (0.16) (0.13)
Free CF/Sh
— — — — — (1.97) (0.65) (0.01) (0.39) (0.67)
Book Value/Sh
— — — — — 6 6 6 6 6
Shares
— — — — — — — — — —
PE Ratio
— — — — — — — — — —
PS Ratio
— — — — — — — — — —
PB Ratio
— — — — — — — — — —
EV/Sales
— — — — — — — — — —
EV/FCF
— — — — — (1) (1) (1) (1) (1)
Op' Cash Flow
— — — — — — — — — —
Capex
— — — — — (1) (1) (1) (1) (1)
FCF
— — — — — 1 0 0 (1) (1)
Working Cap'
— — — — — 1 1 — 1 2
Total Debt
— — — — — 0 1 0 1 2
Net Debt
— — — — — (11) (4) 0 (2) (4)
Sh' Equity
— — — — — 2.10% 4.49% 5.38% (5.60%) (40.23%)
ROA
— — — — — 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC
— — — — — 4.68% 9.30% (399.17%) 122.88% 43.68%
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Chain Bridge I (CBRRF) key facts

  • Chain Bridge I (CBRRF) is a Shell Companies company in the Financial sector.
  • Chain Bridge I reported a net loss of $1.3 million, or a loss of $0.20 per share, for fiscal 2025.
  • As of September 24, 2026, CBRRF traded at $10.31, a market capitalization of $77.4 million.
  • Return on equity was 43.7% and debt-to-equity -0.65.

Source: company filings (standardised) and stockrow calculations.

Chain Bridge I (CBRRF) Latest News

News by impact score

Fine-tune

8 Sep

4

Chain Bridge I (CBRRF) and CommLoan have signed a Letter of Intent to merge, aiming to create a new public company that will enhance the commercial real estate fintech sector. This strategic move is expected to leverage both companies' strengths and expand their market presence. The merger is a significant strategic move that could alter the competitive landscape in the fintech space.

30 Jul

4

Phytanix Bio releases new investor deck highlighting strategic vision and growth potential, enters Business Combination Agreement with Chain Bridge I. The article discusses significant strategic moves and potential impact on Chain Bridge I's future and market performance.

22 Jul

4

Chain Bridge I (CBRG) to acquire Phytanix Bio, creating a new public company focused on developing next-generation cannabinoid and cannabinoid-like medicines. The acquisition of Phytanix Bio and the focus on developing next-generation medicines is expected to have a significant impact on Chain Bridge I's future and market performance.

31 Oct

4

Chain Bridge I will redeem all outstanding public shares and cease operations by November 15, 2023. Redeeming all public shares and ceasing operations will have a significant impact on the company's future and market performance.

4 Aug

4

Institutions hold 58% ownership in Chain Bridge I, influencing share price. Top 9 shareholders own 51% of the business. Significant impact likely on future and performance due to strong institutional backing and potential influence on board decisions.

stockrow.com/CBRRF · For information only; not investment advice. · © 2026 stockrow.com